Treatment with placenta-derived mesenchymal stem cells mitigates development of bronchiolitis obliterans in a murine model

Journal of Thoracic and Cardiovascular Surgery

Volumn 147, Issue 5, 2014, Pages

  Zhao, Yunge ^a   Gillen, Jacob R ^a   Harris, David A ^a   Kron, Irving L ^a   Murphy, Michael P ^b   Lau, Christine L ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 14; EOSIN; HEMATOXYLIN; PHOSPHATE BUFFERED SALINE; PROTEIN P63; TRANSCRIPTION FACTOR FOXP3;

ACUTE GRAFT REJECTION; ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHIOLITIS OBLITERANS; CD3+ T LYMPHOCYTE; CELL PROTECTION; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; DENSITOMETRY; EPITHELIAL PROGENITOR CELL; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LUNG TRANSPLANTATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NEUTROPHIL; NONHUMAN; PLACENTA DERIVED HUMAN MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; STEM CELL; TRACHEA; TRACHEA MUCOSA; TRACHEA SURGERY; TRACHEAL TRANSPLANTATION;

ACUTE DISEASE; ANIMALS; ANTIGENS, CD3; BIOLOGICAL MARKERS; BRONCHIOLITIS OBLITERANS; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EPITHELIAL CELLS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GRAFT REJECTION; HUMANS; KERATIN-14; MACROPHAGES; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEUTROPHIL INFILTRATION; PLACENTA; PREGNANCY; T-LYMPHOCYTES, REGULATORY; TIME FACTORS; TRACHEA; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 84899962031     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2013.09.041     Document Type: Article

References (35)

1. S.M. Fiser, C.G. Tribble, S.M. Long, A.K. Kaza, J.A. Kern, and D.R. Jones et al. Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome Ann Thorac Surg 73 2002 1041 1047
2. A. Chan, and R. Allen Bronchiolitis obliterans: an update Curr Opin Pulm Med 10 2004 133 141
3. L.A. Ortiz, F. Gambelli, C. McBride, D. Gaupp, M. Baddoo, and N. Kaminski et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects Proc Natl Acad Sci U S A 100 2003 8407 8411
4. J. Xu, C.R. Woods, A.L. Mora, R. Joodi, K.L. Brigham, and S. Iyer et al. Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice Am J Physiol Lung Cell Mol Physiol 293 2007 L131 L141
5. N. Gupta, X. Su, B. Popov, J.W. Lee, V. Serikov, and M.A. Matthay Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice J Immunol 179 2007 1855 1863
6. M. Yamada, H. Kubo, S. Kobayashi, K. Ishizawa, M. Numasaki, and S. Ueda et al. Bone marrow-derived progenitor cells are important for lung repair after lipopolysaccharide-induced lung injury J Immunol 172 2004 1266 1272
7. J.W. Lee, X. Fang, A. Krasnodembskaya, J.P. Howard, and M.A. Matthay Concise review: Mesenchymal stem cells for acute lung injury: role of paracrine soluble factors Stem Cells 29 2011 913 919
8. L.A. Ortiz, M. Dutreil, C. Fattman, A.C. Pandey, G. Torres, and K. Go et al. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury Proc Natl Acad Sci U S A 104 2007 11002 11007
9. M. Rojas, J. Xu, C.R. Woods, A.L. Mora, W. Spears, and J. Roman et al. Bone marrow-derived mesenchymal stem cells in repair of the injured lung Am J Respir Cell Mol Biol 33 2005 145 152
10. S. Glennie, I. Soeiro, P.J. Dyson, E.W. Lam, and F. Dazzi Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells Blood 105 2005 2821 2827
11. S. Beyth, Z. Borovsky, D. Mevorach, M. Liebergall, Z. Gazit, and H. Aslan et al. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness Blood 105 2005 2214 2219
12. A.P. Neyrinck, J.W. Lee, X. Fang, N. Gupta, and M.A. Matthay Angiopoietin-1 reverses protein permeability in an injured model of cultured human alveolar epithelial type II cells FASEB J 22 2008 932.6
13. S. Vellasamy, P. Sandrasaigaran, S. Vidyadaran, E. George, and R. Ramasamy Isolation and characterisation of mesenchymal stem cells derived from human placenta tissue World J Stem Cells 4 2012 53 61
14. M.H. Abumaree, M.A. Al Jumah, B. Kalionis, D. Jawdat, A. Al Khaldi, and A.A. AlTalabani et al. Phenotypic and functional characterization of mesenchymal stem cells from chorionic villi of human term placenta Stem Cell Rev 9 2013 16 31
15. X. Luan, G. Li, G. Wang, F. Wang, and Y. Lin Human placenta-derived mesenchymal stem cells suppress T cell proliferation and support the culture expansion of cord blood CD34+ cells: a comparison with human bone marrow-derived mesenchymal stem cells Tissue Cell 45 2013 32 38
16. K.J. Liu, C.J. Wang, C.J. Chang, H.I. Hu, P.J. Hsu, and Y.C. Wu et al. Surface expression of HLA-G is involved in mediating immunomodulatory effects of placenta-derived multipotent cells (PDMCs) towards natural killer lymphocytes Cell Transplant 20 2011 1721 1730
17. W. Yuan, C. Zong, Y. Huang, Y. Gao, D. Shi, and C. Chen et al. Biological, immunological and regenerative characteristics of placenta-derived mesenchymal stem cell isolated using a time-gradient attachment method Stem Cell Res 9 2012 110 123
18. A.K. Sharma, G. Lu, A. Jester, W.F. Johnston, Y. Zhao, and V.A. Hajzus et al. Experimental abdominal aortic aneurysm formation is mediated by IL-17 and attenuated by mesenchymal stem cell treatment. Circulation. 2012;126(11 Suppl 1):S38-45 Erratum in: Circulation 126 2012 e278
19. C.L. Lau, Y. Zhao, I.L. Kron, M.H. Stoler, V.E. Laubach, and G. Ailawadi et al. The role of adenosine A2A receptor signaling in bronchiolitis obliterans Ann Thorac Surg 88 2009 1071 1078
20. Y. Zhao, J.F. Steidle, G.R. Upchurch, I.L. Kron, and C.L. Lau Prevention of the second stage of epithelial loss is a potential novel treatment for bronchiolitis obliterans J Thorac Cardiovasc Surg 145 2013 940 947
21. Y. Zhao, A.K. Sharma, D.J. LaPar, I.L. Kron, G. Ailawadi, and Y. Liu et al. Depletion of tissue plasminogen activator attenuates lung ischemia-reperfusion injury via inhibition of neutrophil extravasation Am J Physiol Lung Cell Mol Physiol 300 2011 L718 L729
22. E. Candi, R. Cipollone, P. Rivetti di Val Cervo, S. Gonfloni, and G. Melino et al. p63 in epithelial development Cell Mol Life Sci 65 2008 3126 3133
23. J.R. Rock, and B.L. Hogan Epithelial progenitor cells in lung development, maintenance, repair, and disease Annu Rev Cell Dev Biol 27 2011 493 512
24. A. Bharat, K. Narayanan, T. Street, R.C. Fields, N. Steward, and A. Aloush et al. Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection Transplantation 83 2007 150 158
25. D.A. Grove, J. Xu, R. Joodi, E. Torres-Gonzales, D. Neujahr, and A.L. Mora et al. Attenuation of early airway obstruction by mesenchymal stem cells in a murine model of heterotopic tracheal transplantation J Heart Lung Transplant 30 2011 341 350
26. E. Puchelle, and B. Peault Human airway xenograft models of epithelial cell regeneration Respir Res 1 2000 125 128
27. N. Qu, P. de Vos, M. Schelfhorst, A. de Haan, W. Timens, and J. Prop Integrity of airway epithelium is essential against obliterative airway disease in transplanted rat tracheas J Heart Lung Transplant 24 2005 882 890
28. P. Soroosh, T.A. Doherty, W. Duan, A.K. Mehta, H. Choi, and Y.F. Adams et al. Lung-resident tissue macrophages generate Foxp3+ regulatory T cells and promote airway tolerance J Exp Med 210 2013 775 788
29. G. Zhen, H. Liu, N. Gu, H. Zhang, Y. Xu, and Z. Zhang Mesenchymal stem cells transplantation protects against rat pulmonary emphysema Front Biosci 13 2008 3415 3422
30. G.Y. Wang, S.Y. Zhang, G.Y. Li, F.F. Wang, DU HB, and X.Y. Luan The effect of human placenta-derived mesenchymal stem cells on cord blood CD8(+); T cells activation, cell cycle and secretion of IL-17 Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 28 2012 17 20 [in Chinese]
31. J.M. Lee, J. Jung, H.J. Lee, S.J. Jeong, K.J. Cho, and S.G. Hwang et al. Comparison of immunomodulatory effects of placenta mesenchymal stem cells with bone marrow and adipose mesenchymal stem cells Int Immunopharmacol 13 2012 219 224
32. R.A. Shilling, and D.S. Wilkes Role of Th17 cells and IL-17 in lung transplant rejection Semin Immunopathol 33 2011 129 134
33. T. Nakagiri, M. Inoue, M. Minami, Y. Shintani, and M. Okumura Immunology mini-review: the basics of T(H)17 and interleukin-6 in transplantation Transplant Proc 44 2012 1035 1040
34. A. Bharat, R.C. Fields, N. Steward, E.P. Trulock, G.A. Patterson, and T. Mohanakumar CD4+25+ regulatory T cells limit Th1-Autoimmunity by inducing IL-10 producing T cells following human lung transplantation Am J Transplant 6 2006 1799 1808
35. Q. Shi, H. Cao, J. Liu, X. Zhou, Q. Lan, and S. Zheng et al. CD4+ Foxp3+ regulatory T cells induced by TGF-β, IL-2 and all-trans retinoic acid attenuate obliterative bronchiolitis in rat trachea transplantation Int Immunopharmacol 11 2011 1887 1894